4.7 Article

Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation

Related references

Note: Only part of the references are listed.
Article Cell & Tissue Engineering

Hypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application

Yanmeng Yang et al.

Summary: Mesenchymal stem cells (MSCs) are promising cell sources for tissue regeneration due to their self-regeneration, differentiation, and immunomodulation abilities. Preconditioning MSCs with hypoxia can improve their therapeutic potential by enhancing cell functionality and survival, as well as promoting cell proliferation and migration.

TISSUE ENGINEERING PART B-REVIEWS (2022)

Review Chemistry, Multidisciplinary

Druggability of lipid metabolism modulation against renal fibrosis

Yuan-yuan Chen et al.

Summary: Renal fibrosis, a common pathological process in chronic kidney disease leading to kidney failure, lacks effective drugs for treatment. Dysfunctional lipid metabolism exacerbates chronic kidney disease and fibrosis, while restoring fatty acid oxidation may alleviate renal fibrosis.

ACTA PHARMACOLOGICA SINICA (2022)

Article Chemistry, Multidisciplinary

Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Mitochondrial Damage and Inflammation by Stabilizing Mitochondrial DNA

Meng Zhao et al.

Summary: The study demonstrates that MSC-EVs can alleviate mtDNA damage and inflammation after acute kidney injury, with their effects partially dependent on the TFAM signaling pathway. This suggests that MSC-EVs are promising nanotherapeutics for diseases characterized by mitochondrial damage, highlighting the essential role of TFAM in maintaining their regenerative capacity.

ACS NANO (2021)

Article Engineering, Biomedical

Hypoxic pretreatment of small extracellular vesicles mediates cartilage repair in osteoarthritis by delivering miR-216a-5p

Yuluo Rong et al.

Summary: The study demonstrated that hypoxic pretreatment of small extracellular vesicles effectively protected cartilage from degeneration and slowed down the progression of OA. Through the miR-216a-5p/JAK2/STAT3 pathway, hypoxic pretreatment is promising for optimizing the therapeutic effects of BMSC-derived sEVs.

ACTA BIOMATERIALIA (2021)

Review Medicine, Research & Experimental

Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis

Hao Yan et al.

Summary: Renal fibrosis, a common pathological marker of chronic kidney disease, is characterized by the activation and proliferation of renal fibroblasts and excessive synthesis of extracellular matrix in the renal interstitium. Effective treatments specifically targeting renal fibrosis are still lacking, highlighting the need for novel therapeutic targets and approaches.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Biochemistry & Molecular Biology

Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences

Sara Panizo et al.

Summary: Fibrosis is a process of excessive accumulation of extracellular matrix in response to tissue injuries, which can lead to organ dysfunction. While it can play a defensive role, in certain circumstances it can become pathological and have negative impacts on kidney and heart in CKD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Urology & Nephrology

Mitochondrial quality control in kidney injury and repair

Chengyuan Tang et al.

Summary: Mitochondria play crucial roles in eukaryotic cells, and dysfunction can lead to kidney diseases. Protecting mitochondrial homeostasis may prevent and treat kidney injury, representing a potential therapeutic strategy.

NATURE REVIEWS NEPHROLOGY (2021)

Article Cell Biology

P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury

Yingying Qian et al.

Summary: The study found that P2X7 receptor deficiency can protect the kidney from ischemia-reperfusion injury and attenuate the formation of NLRP3 inflammasome. Blocking the extracellular ATP/P2X7 receptor axis may protect renal tubular epithelial cells from ischemia-reperfusion injury through the regulation of NLRP3 inflammasome.

CELL DEATH & DISEASE (2021)

Article Pharmacology & Pharmacy

Role of the CTRP6/AMPK pathway in kidney fibrosis through the promotion of fatty acid oxidation

Yu-hong Xie et al.

Summary: CTRP6, an adiponectin analogue, plays a critical role in fibrotic diseases by regulating FAO and AMPK activation. It inhibits ECM deposition and promotes AMPK phosphorylation by promoting FAO, thereby regulating TGF-beta 1-induced renal tubular epithelial cell differentiation.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Medicine, Research & Experimental

Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis

Veronica Miguel et al.

Summary: The study found that promoting fatty acid oxidation to increase mitochondrial oxidative metabolism can protect against kidney fibrosis, as demonstrated in animal models and patients with chronic kidney disease.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Biochemistry & Molecular Biology

Nuclear receptors in the kidney during health and disease

Andrew E. Libby et al.

Summary: Over the past 30 years, nuclear receptors (NRs) have been recognized as key modulators in maintaining systemic homeostasis and contributing to various diseases, particularly in the kidney where they play crucial roles in regulating processes such as circadian responses and lipid metabolism. Recent advances in genetic tools and small molecule modulators have enabled detailed studies on how renal NRs impact kidney homeostasis and progression of diseases. Understanding dysregulation of NRs in renal conditions over the last decade has significantly shaped our knowledge of renal disease etiology, making NRs attractive therapeutic targets.

MOLECULAR ASPECTS OF MEDICINE (2021)

Review Cell & Tissue Engineering

Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases

Yuling Huang et al.

Summary: MSC-EVs have demonstrated significant therapeutic effects on acute kidney injury, chronic kidney disease, diabetic nephropathy, and atherosclerotic renovascular disease, while their roles in transplanted kidneys remain controversial.

STEM CELL RESEARCH & THERAPY (2021)

Review Peripheral Vascular Disease

Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?

Alfonso Eirin et al.

Summary: MSC-derived extracellular vesicles (EVs) have the potential to modulate pathways responsible for renal injury, including inflammation, oxidative stress, apoptosis, fibrosis, and microvascular remodeling, leading to renoprotective effects in experimental studies. However, scarce clinical data and challenges such as standardization of methods for EV isolation and characterization, EV fate, duration of EV effects, and effects of cardiovascular risk factors need to be addressed for successful clinical translation.

HYPERTENSION (2021)

Review Biochemistry & Molecular Biology

Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury

Lucy Birtwistle et al.

Summary: This review discusses mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) as a novel therapeutic approach for chronic kidney disease, highlighting their ability to promote kidney regeneration and slow down the progression of pathophysiological pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity

Zhixiao Luo et al.

Summary: The study showed that Astragaloside IV (AST) has significant effects on fat metabolism in ageing mice, reducing body weight and fat content, promoting fatty acid metabolism, and enhancing mitochondrial activity.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Medicine, General & Internal

Chronic kidney disease

Kamyar Kalantar-Zadeh et al.

Summary: Chronic kidney disease is a progressive disease with no cure, and preserving kidney function through lifestyle adjustments and pharmacological interventions can improve outcomes. A plant-dominant, low-protein, and low-salt diet may help mitigate glomerular hyperfiltration and preserve renal function. Various pharmacotherapies can also be used to alter intrarenal haemodynamics and protect the kidney from further damage.

LANCET (2021)

Article Cell Biology

Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI

Zhihuang Zheng et al.

Summary: The study suggests that YAP plays a crucial role in chronic inflammation induced by AKI, with YAP activation enhancing MCP-1 expression leading to aggravated renal inflammation, contributing to AKI-CKD transition.

CELL DEATH & DISEASE (2021)

Article Biotechnology & Applied Microbiology

Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K/Akt pathways

Jie Wang et al.

Summary: Research indicates that hypoxic adipose stem cells exosomes (HypADSCs-exo) can promote diabetic wound healing by regulating miRNAs and the PI3K/AKT signaling pathway, inhibiting inflammatory response.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Biotechnology & Applied Microbiology

Targeting metabolic dysregulation for fibrosis therapy

Xiao Zhao et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Cell & Tissue Engineering

Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats

Naoki Ishiuchi et al.

STEM CELL RESEARCH & THERAPY (2020)

Article Cell Biology

Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy

Sharad Kholia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid

Omar Emiliano Aparicio-Trejo et al.

FREE RADICAL BIOLOGY AND MEDICINE (2020)

Review Urology & Nephrology

AKI: an increasingly recognized risk factor for CKD development and progression

J. T. Kurzhagen et al.

JOURNAL OF NEPHROLOGY (2020)

Review Physiology

Mitochondrial dysfunction and the AKI-to-CKD transition

Mingzhu Jiang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)

Review Cell Biology

Hypoxia and extracellular vesicles: A review on methods, vesicular cargo and functions

Nea Bister et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Review Medicine, General & Internal

Acute kidney injury

Claudio Ronco et al.

LANCET (2019)

Article Urology & Nephrology

ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis

Tzu-Ming Jao et al.

KIDNEY INTERNATIONAL (2019)

Review Pharmacology & Pharmacy

Targeting renal fibrosis: Mechanisms and drug delivery systems

Madalina V. Nastase et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Review Physiology

Mechanisms of Renal Fibrosis

Benjamin D. Humphreys

ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)

Review Endocrinology & Metabolism

Molecular Actions of PPARα in Lipid Metabolism and Inflammation

Nadia Bougarne et al.

ENDOCRINE REVIEWS (2018)

Review Biochemistry & Molecular Biology

Renal fibrosis: Primacy of the proximal tubule

Leslie S. Gewin

MATRIX BIOLOGY (2018)

Review Cell Biology

The multifaceted contributions of mitochondria to cellular metabolism

Jessica B. Spinelli et al.

NATURE CELL BIOLOGY (2018)

Review Cell Biology

Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy

Jennifer Phan et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Review Biochemistry & Molecular Biology

The Peroxisome-Mitochondria Connection: How and Why?

Marc Fransen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Medicine, Research & Experimental

Distinct but complementary contributions of PPAR isotypes to energy homeostasis

Vanessa Dubois et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Urology & Nephrology

Mitochondrial energetics in the kidney

Pallavi Bhargava et al.

NATURE REVIEWS NEPHROLOGY (2017)

Article Urology & Nephrology

Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism

Seung Hyeok Han et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)